Cargando…
A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer
Cuprotosis, a newly proposed mechanism of cell death, can trigger acute oxidative stress that leads to cell death by mediating protein lipidation in the tricarboxylic acid cycle. However, cuprotosis-related long non-coding RNAs (CRLNCs) and their relationship with prognosis and the immunological lan...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709405/ https://www.ncbi.nlm.nih.gov/pubmed/36465903 http://dx.doi.org/10.3389/fmed.2022.1055785 |
_version_ | 1784841147055603712 |
---|---|
author | Li, Wei Yang, Guiyun Dong, Hao Zhu, Jiajing Liu, Tongjun |
author_facet | Li, Wei Yang, Guiyun Dong, Hao Zhu, Jiajing Liu, Tongjun |
author_sort | Li, Wei |
collection | PubMed |
description | Cuprotosis, a newly proposed mechanism of cell death, can trigger acute oxidative stress that leads to cell death by mediating protein lipidation in the tricarboxylic acid cycle. However, cuprotosis-related long non-coding RNAs (CRLNCs) and their relationship with prognosis and the immunological landscape of colorectal cancer (CRC) are unclear. We have developed a lncRNA signature to predict survival time, immune infiltration, and sensitivity to chemotherapy. CRLNCs were screened using the Cor function of the R software and the differentially expressed lncRNAs were collected with the limma package. Differentially expressed long non-coding RNAs (lncRNAs) associated with prognosis were selected using univariate regression analysis. A prognostic signature was developed using the least absolute shrinkage and selection operator (LASSO) and multivariate regression analysis. Patients with CRC were divided into two groups based on the risk score. The low-risk group had a more favorable prognosis, higher expression of immune checkpoints, and a higher level of immune cell infiltration compared with the high-risk group. Furthermore, there was a close association between the risk score and the clinical stage, tumor mutational burden, cancer stem cell index, and microsatellite instability. We also assessed chemotherapy response in the two risk groups. Our study analyzed the role of CRLNCs in CRC and provided novel targets and strategies for CRC chemotherapy and immunotherapy. |
format | Online Article Text |
id | pubmed-9709405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97094052022-12-01 A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer Li, Wei Yang, Guiyun Dong, Hao Zhu, Jiajing Liu, Tongjun Front Med (Lausanne) Medicine Cuprotosis, a newly proposed mechanism of cell death, can trigger acute oxidative stress that leads to cell death by mediating protein lipidation in the tricarboxylic acid cycle. However, cuprotosis-related long non-coding RNAs (CRLNCs) and their relationship with prognosis and the immunological landscape of colorectal cancer (CRC) are unclear. We have developed a lncRNA signature to predict survival time, immune infiltration, and sensitivity to chemotherapy. CRLNCs were screened using the Cor function of the R software and the differentially expressed lncRNAs were collected with the limma package. Differentially expressed long non-coding RNAs (lncRNAs) associated with prognosis were selected using univariate regression analysis. A prognostic signature was developed using the least absolute shrinkage and selection operator (LASSO) and multivariate regression analysis. Patients with CRC were divided into two groups based on the risk score. The low-risk group had a more favorable prognosis, higher expression of immune checkpoints, and a higher level of immune cell infiltration compared with the high-risk group. Furthermore, there was a close association between the risk score and the clinical stage, tumor mutational burden, cancer stem cell index, and microsatellite instability. We also assessed chemotherapy response in the two risk groups. Our study analyzed the role of CRLNCs in CRC and provided novel targets and strategies for CRC chemotherapy and immunotherapy. Frontiers Media S.A. 2022-11-16 /pmc/articles/PMC9709405/ /pubmed/36465903 http://dx.doi.org/10.3389/fmed.2022.1055785 Text en Copyright © 2022 Li, Yang, Dong, Zhu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Li, Wei Yang, Guiyun Dong, Hao Zhu, Jiajing Liu, Tongjun A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer |
title | A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer |
title_full | A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer |
title_fullStr | A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer |
title_full_unstemmed | A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer |
title_short | A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer |
title_sort | prognostic signature based on cuprotosis-related long non-coding rnas predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709405/ https://www.ncbi.nlm.nih.gov/pubmed/36465903 http://dx.doi.org/10.3389/fmed.2022.1055785 |
work_keys_str_mv | AT liwei aprognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT yangguiyun aprognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT donghao aprognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT zhujiajing aprognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT liutongjun aprognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT liwei prognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT yangguiyun prognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT donghao prognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT zhujiajing prognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer AT liutongjun prognosticsignaturebasedoncuprotosisrelatedlongnoncodingrnaspredictstheprognosisandsensitivitytochemotherapyinpatientswithcolorectalcancer |